The present invention relates to compounds of formula (I) as GPR65 modulators for the treatment of a proliferative disorder, such as e.g. cancer, an immune disorder, asthma, chronic obstructive pulmonary disease (CORD) or acute respiratory distress syndrome (ARDS). Preferred compounds are e.g. N-(Pyridin-2-yl)-6,7,8,9- tetrahydro-5H-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds, such as e.g. (5R,8S)-N- (4-chloro-5-(trifluoromethyl)pyridin-2-yl)-l-fluoro-6,7,8,9- tetrahydro-5H-5,8-epiminocyclohepta[c]pyridine-10-carboxamide (compound 1)
本发明涉及式(I)化合物作为GPR65调节剂,用于治疗增殖性疾病,例如癌症、免疫性疾病、哮喘、慢性阻塞性肺病(
COPD)或急性呼吸窘迫综合征(ARDS)。优选的化合物例如是N-(
吡啶-2-基)-6,7,8,9-四氢-5H-5,8-环丙
氨基七环[c]
吡啶-10-羧酰胺衍
生物和类似化合物,例如(5R,8S)-N-(4-
氯-5-(三
氟甲基)
吡啶-2-基)-1-
氟-6,7,8,9-四氢-5H-5,8-环丙
氨基七环[c]
吡啶-10-羧酰胺(化合物1)。